Maternal Medicine Flashcards
Be able to demonstrate a detailed understanding of the issues relating to pregnancy complicated by diabetes mellitus.
-
Foetal abnormalities
- 5mg folic acid supplementation from preconception until 12 weeks gestation
- Pre-conception HbA1c target of 48mmol/L
-
Use of medications
- Insulin and/or metformin can be used prior to conception and during pregnancy
- Medications for co-morbidities should also be reviewed e.g. ACEis and statins
-
Development/progression of retinopathy
- Screening at booking and at 28 weeks gestation
- Other diabetic complications should also be monitored for (nephropathy, neuropathy, hypertension, thryroid disease)
-
Increased risk of pre-eclampsia
- 75mg aspirin to be taken from 12 weeks gestation
- Increased monitoring of maternal BP and proteinuria
-
Increased risk of foetal macrosomia or IUGR
- Regular growth scans arranged for monitoring
-
Increased risk of stillbirth as gestation progresses
- Planned delivery between 37 and 38 + 6 weeks (before 39 weeks)
-
Control of maternal blood glucose levels during labour
- Sliding scale insulin regime is considered for mothers with T1DM during labour
-
Neonatal complications
- Hypoglycaemia, polycythaemia, jaundice, congenital heart disease and cardiomyopathy
Be able to demonstrate some knowledge and experience in the diagnosis and management of pregnancy complicated by obesity.
Obesity in pregnancy is defined as BMI of 30 kg/m2 or higher at the first antenatal consultation.
Management
Pre-conception
- 5-10% weight loss can be enough to improve health during pregnancy
- Ideal BMI is 18.5 - 24.9 kg/m2
- A reduction in BMI can increase the chance of conceiving
- 5mg folic acid
During pregnancy
- Reducing risk of foetal macrosomia:
- Weight gain during pregnancy expected to be less than those of ‘normal’ weight, 7 - 11.5kg for overweight and 5-9kg for obese (compared to 11.5-16kg)
- Dispel ‘eating for 2’ myth. No need to increase calorific intake until 6 months, ~ 200 cals/day is sufficient
- 5mg folic acid and 10 micrograms vitamin D supplementation until 12 weeks gestation
- Management of increased VTE risk
- BMI > 30 kg/h2 → VTE assessment at booking
- > 3 risk factors → LMWH should be prescribed and continued until 6/52 following delivery
- Management of increased risk of pre-eclampsia
- 75mg aspirin throughout pregnancy
- Management of increased risk of GDM
- OGTT between 24 - 28 weeks
- Loss of SFH accuracy in obese patients
- Serial growth US scans are instead performed from 28 weeks
During Labour
- BMI > 35 kg/h2 → delivery in an obs, rather than midwife led, unit
- FSE may be required to allow improved foetal monitoring, as CTG is often difficult
After Delivery
- Ongoing VTE prophylaxis as indicated
- 6/52 check of fasting glucose for those with GDM
Be able to demonstrate some knowledge and experience in the diagnosis and management of pregnancy complicated by thrombophilia.
Diagnosis: Antenatal assessment of VTE risk should be performed.
Management *dependent on level of risk for VTE development*
Previous VTE assoicated with antithrombin deficiency → Higher dose LMWH
NOTE - Dehydration is a risk factor for VTE, hence patients with hyperemesis gravidarum and OHSS should be provided with LMWH, providing that delivery is not imminent
Be able to demonstrate some knowledge and experience in the diagnosis and management of pregnancy complicated by pre-existing hypertension.
Diagnosis:
BP of > 140/90 mmHg at booking OR within the first 20 weeks of pregnancy.2
- If new, look to exclude secondary causes of hypertension e.g. CoA, renal artery stenosis, Cushing syndrome etc.
*** BP > 160/110 mmHg in pregnancy is a medical emergency
Management
- Increased risk of pre-eclampsia, foetal growth restriction and placental abruption.
- Cessation of inappropriate anti-hypertensives (increased risk of congential abnormalities)
- ACEis, ARBs, thiazide diuretics should be changed to labetalol or methyldopa
- Aim for 135/85 mmHg
- Increased risk of developing pre-eclampsia
- 75-150 mmHg of aspirin from conception
- Monitoring for foetal growth restriction
- US every 4/52 from 28 weeks gestation
- Umbilical artery doppler, amniotic fluid volume assessment and foetal growth should be assessed
- Monitor BP hourly through labour (or continuously if >160/100)
- Oxytocin ONLY1 at the 3rd stage of labour
- Post-natal medications
- Methyldopa should be changed to another hypertensive after delivery (risk of postnatal depression)
- Diuretics should be avoided if breast feeding
1: Syntometrine (ergometrine + oxytocin) causes severe hypertension, increasing the risk of stroke
2: New onset hypertension occurring in the second half of pregnancy is gestational hypertension.
Be able to demonstrate some knowledge and experience in the diagnosis and management of pregnancy complicated by epilepsy.
Diagnosis: 2 or more seizures 24 hours apart, or a single seizure characteristic of an epilepsy sydrome.
Management:
- Pre-conceptual advice
- Aim to be seizure free for at least 2/12 before conception
- 5mg folic acid, continued until 12 weeks gestation
- Lifestyle advice to minimise risk if a seizure should occur: avoid swimming, shower instead of bath, ensure adequate sleep and the effects of vomiting on AEDs
- AED use in pregnancy
- Monotherapy is often safer
- Lamotrigine and carbamazepine are regarded as the safest drug choices in pregnancy
- Adjusting AED levels to compensate for changes seen in pregnancy
- Sodium valporate and lamotrigine levels should be monitored in pregnancy (each trimester)
- Increased risk of foetal malformations (neural tube defects, cleft lips/palates, heart defects)
- Detailed cardiac USS offered at 16 weeks, or as part of the anomaly scan
- Labour carries the highest risk of seizures
- Avoid pethidine, as it lowers the seizure threshold
- Continuous CTG monitoring is required
- Ensure good hydration and pain relief
Be able to demonstrate an awareness of the issues involved in the diagnosis and management of pregnancy complicated by HIV.
Diagnosis:
Screening is performed at the booking appointment (plus syphilis and HBV).
Management:
- Viral load monitoring
- Viral load and CD4 should also be established in HIV positive mothers.
- Viral load monitoring should be performed each trimester, at 36 weeks and around the time of delivery
- Reducing risk of transmission to the foetus
- Pre-conceptual optimisation of ART (combination therapy of at least 3 antiretroviral drugs)
- Decide mode of delivery by 36 weeks (elective C-section if viral load is high)
- Neonate commenced on ART once born, continued for at least 4/52
- Advise against breastfeeding, due to risk of transmission
- Screen for other STIs and other opportunistic infections
- HBV, HCV, varicella, syphilis, rubella, measles and toxoplasmosis
Be able to demonstrate an awareness of the issues involved in the diagnosis and management of pregnancy complicated by of cardiac disease.
Diagnosis
- Symptoms indicative of cardiac disease include syncope, dyspnoea, fatigue, orthopnoea, chest pain and palpitations. Raised JVP and oedema may be seen
- Raised RR, tachycardia and orthopnoea are important symptoms which require investigation
- Arrhythmias and heart failure are the most common complications to arise during pregnancy. MI and valvular problems may also arise.
Management
- Regular review in joint obstetric and cardiology clinic
- Review symptoms
- Investigations (e.g. ECHO) to monitor disease progression
- Discuss timing and mode of delivery
- Note that pushing in the 2nd phase of labour is particularly stressing on the CV system, hence C-section may be considered a safer option
- Must give birth in hospital; have epidural, continuous CTG and abx
- Postnatal follow-up is essential
Specific cases
Peripartum cardiomyopathy: Heart dilates and weakens during pregnancy, inducing heart failure symptoms (fatigue, SOB and fluid retention).
Hypertrophic obstructive cardiomyopathy: Increasingly diagnosed in pregnant women. An adult onset condition associated with a FHx
Be able to demonstrate an awareness of the issues involved in the diagnosis and management of pregnancy complicated by other chronic maternal conditions.
Hypothyroidism
- Untreated or under-treated hypothyroidism can leads to miscarriage, anaemia, SGA and pre-eclampsia
- As the foetal thyroid gland does not develop fully until 16 weeks gestation the foetus relies on maternal thyroid hormone prior to this
- Levothyroxine is safe for use during pregnancy and can cross the placenta
Rheumatoid arthritis
- Ideally, symptoms should be well controlled for at least 3/12 before pregnancy
- Symptoms often improve during pregnancy and then flare following delivery
- Medication choice during pregnancy
- Methotrexate is contraindicated *teratogenic - miscarriage and congenital abnormalities*
- Hydroxychloroquine is considered safe (often 1st line)
- Sulfasalazine is considered pregnancy